N

NBP

NBP

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
13%Bearish
Buy/Sell Ratio79% buys
BearishBullish
NBP Live QuoteReal-time
$0.83
$0.50(-37.59%)1M
Day Range$0.82 – $0.98
Open$0.89
Previous Close$0.88
Volume991.5K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$102.06M
P/E Ratio (TTM)24.5
Forward P/E2.7
EPS (TTM)$-0.69
Price to Book0.5
Dividend Yield0.65%
Beta (Volatility)1.72
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $0.83 (2%)
Low: $0.75High: $5.19
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$8.67-94.2% upside

Insider Buys

1

$577K

Insider Sales

7

$154K

Total Volume

$732K

8 transactions

Net Activity

+$423K

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
65CONFIDENCE

Sentiment Rating

Moderate Accumulation

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Strong buying bias: purchases represent 79% of total transaction value.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
H
1

Hagler Mark Arnold

See Remarks

1 buys0 sells

$577K total

C
2

Cao Sean Wuxiong

Chief Bus. Development Officer

0 buys2 sells

$122K total

X
3

Xu Cong Claire

EVP, Clinical Development

0 buys3 sells

$20K total

D
4

Dennis Phillip Andrew

Chief Medical Officer

0 buys2 sells

$11K total

Trading History
NBP insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Sep 18, 2026

2 months ago

Dennis Phillip Andrew

Chief Medical Officer

C-Level
Sell8.2K$0.71$6K

Sep 9, 2026

2 months ago

Cao Sean Wuxiong

Chief Bus. Development Officer

C-Level
Sell108.0K$0.74$80K

Aug 31, 2026

2 months ago

Xu Cong Claire

EVP, Clinical Development

EVP
Sell3.3K$0.79$3K

Jul 6, 2026

4 months ago

Xu Cong Claire

SVP, Clinical Development

SVP
Sell4.5K$0.89$4K

Jun 18, 2026

5 months ago

Dennis Phillip Andrew

Chief Medical Officer

C-Level
Sell8.5K$0.66$6K

Jun 1, 2026

5 months ago

Xu Cong Claire

SVP, Clinical Development

SVP
Sell3.5K$3.94$14K

May 14, 2026

6 months ago

Cao Sean Wuxiong

See Remarks

Insider
Sell21.4K$1.99$43K

Apr 24, 2026

7 months ago

Hagler Mark Arnold

See Remarks

Insider
Buy230.0K$2.51$577K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
NBP Buy Conviction79%
Industry Rank#0 of 569
Volume Contribution0.0%
Total Industry Activity$16.52B

NBP has an insider buy conviction of 79%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for NBP

Over the last 90 days, corporate insiders at NBP (NBP) engaged in a total of 8 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 7 were sales. The total volume of insider trading reached $732K.

The net insider activity for NBP shows a net buying bias of $423K. This activity represents a 79% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Purchase by Hagler Mark Arnold (See Remarks), who traded 230.0K shares valued at $577K on Apr 24, 2026.

Live Market News & Developments
Aggregated real-time headlines for NBP (NBP)
6 updates

NovaBridge Biosciences (NBP) Stock Price, News, Quote & History

Yahoo! Finance Canada13h ago

NovaBridge Biosciences (Nasdaq:NBP) - Stock Analysis

Simply Wall St2d ago

NovaBridge Biosciences (NBP) stock price, news, quote and history

Yahoo Finance UKYesterday

NBP Stock Discussion and Investor Sentiment - National Bank Of Pakistan

Investify11h ago

A trial will test if patients can wait up to seven months between eye injections after three monthly doses.

Stock Titan2d ago

NovaBridge: Rebranded, Repackaged, But Far From De-Risked (NASDAQ:NBP)

Seeking Alpha139d ago

FAQs About NBP Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for NBP.

Based on SEC Form 4 disclosures, the Insider Confidence Score for NBP is currently 65/100, which reflects a moderate accumulation bias. This calculation accounts for a total of 1 purchases and 7 sales by company executives over the last 90 days.

The CEO Conviction Index for NBP is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.